Follicular thyroid carcinoma but not adenoma recruits tumor-associated macrophages by releasing CCL15

被引:17
|
作者
Huang, Feng-Jiao [1 ,2 ]
Zhou, Xiao-Yi [1 ,2 ]
Ye, Lei [1 ,2 ]
Fei, Xiao-Chun [3 ]
Wang, Shu [1 ,2 ,4 ,5 ]
Wang, Weiqing [1 ,2 ]
Ning, Guang [1 ,2 ,4 ,5 ]
机构
[1] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med,Shanghai Key Lab Endocrine Tumors, Shanghai Clin Ctr Endocrine & Metab Dis,Shanghai, 197 Ruijin 2nd Rd, Shanghai 200025, Peoples R China
[2] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Shanghai E Inst Endocrinol, 197 Ruijin 2nd Rd, Shanghai 200025, Peoples R China
[3] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Pathol, 197 Ruijin 2nd Rd, Shanghai 200025, Peoples R China
[4] Shanghai Jiao Tong Univ, Sch Med, Inst Hlth Sci, Lab Endocrine & Metab Dis, 227 South Chongqing Rd, Shanghai 200025, Peoples R China
[5] Chinese Acad Sci, Shanghai Inst Biol Sci, 227 South Chongqing Rd, Shanghai 200025, Peoples R China
来源
BMC CANCER | 2016年 / 16卷
基金
美国国家科学基金会;
关键词
Follicular thyroid carcinoma; Follicular adenoma; Tumor-associated macrophages; CCL15; COLONY-STIMULATING FACTOR; CCR1(+) MYELOID CELLS; LYMPH-NODE METASTASIS; DIFFERENTIAL-DIAGNOSIS; CANCER; EXPRESSION; PROGRESSION; PROMOTE; MICROENVIRONMENT; CLASSIFICATION;
D O I
10.1186/s12885-016-2114-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The differential diagnosis of follicular thyroid carcinoma (FTC) and follicular adenoma (FA) before surgery is a clinical challenge. Many efforts have been made but most focusing on tumor cells, while the roles of tumor associated macrophages (TAMs) remained unclear in FTC. Here we analyzed the differences between TAMs in FTC and those in FA. Methods: We first analyzed the density of TAMs by CD68 immunostaining in 59 histologically confirmed FTCs and 47 FAs. Cytokines produced by FTC and FA were profiled using antibody array, and validated by quantitative PCR. Chemotaxis of monocyte THP-1 was induced by condition medium of FTC cell lines (FTC133 and WRO82-1) with and without anti-CCL15 neutralizing antibody. Finally, we analyzed CCL15 protein level in FTC and FA by immunohistochemistry. Results: The average density of CD68(+) cells was 9.5 +/- 5.4/field in FTC, significantly higher than that in FA (4.9 +/- 3.4/field, p < 0.001). Subsequently profiling showed that CCL15 was the most abundant chemokine in FTC compared with FA. CCL15 mRNA in FTC was 51.4-folds of that in FA. CM of FTC cell lines induced THP-1 cell chemotaxis by 33 similar to 77 %, and anti-CCL15 neutralizing antibody reduced THP-1 cell migration in a dose-dependent manner. Moreover, we observed positive CCL15 immunostaining in 67.8 % of FTCs compared with 23.4 % of FAs. Conclusion: Our study suggested FTC might induce TAMs infiltration by producing CCL15. Measurement of TAMs and CCL15 in follicular thyroid lesions may be applied clinically to differentiate FTC from FA pre-operation.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Tumor-associated cytotoxic lymphocytes and macrophages as predictive factors in follicular lymphoma
    Nesterova E.S.
    Kravchenko S.K.
    Gemdjian E.G.
    Osmanov E.A.
    Kovrigina A.M.
    Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology, 2014, 8 (2) : 198 - 205
  • [22] Tumor-Associated Macrophages (TAMs) Form an Interconnected Cellular Supportive Network in Anaplastic Thyroid Carcinoma
    Caillou, Bernard
    Talbot, Monique
    Weyemi, Urbain
    Pioche-Durieu, Catherine
    Al Ghuzlan, Abir
    Bidart, Jean Michel
    Chouaib, Salem
    Schlumberger, Martin
    Dupuy, Corinne
    PLOS ONE, 2011, 6 (07):
  • [23] Tumor-associated macrophages as a potential therapeutic target in thyroid cancers
    Zhu, Liya
    Li, Xiu Juan
    Gangadaran, Prakash
    Jing, Xiuli
    Ahn, Byeong-Cheol
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (12) : 3895 - 3917
  • [24] Tumor-associated macrophages as a potential therapeutic target in thyroid cancers
    Liya Zhu
    Xiu Juan Li
    Prakash Gangadaran
    Xiuli Jing
    Byeong-Cheol Ahn
    Cancer Immunology, Immunotherapy, 2023, 72 : 3895 - 3917
  • [25] Tumor-associated macrophages derived CCL18 promotes metastasis in squamous cell carcinoma of the head and neck
    Li She
    Yuexiang Qin
    Juncheng Wang
    Chao Liu
    Gangcai Zhu
    Guo Li
    Ming Wei
    Changhan Chen
    Guancheng Liu
    Diekuo Zhang
    Xiyu Chen
    Yunyun Wang
    Yuanzheng Qiu
    Yongquan Tian
    Xin Zhang
    Yong Liu
    Donghai Huang
    Cancer Cell International, 18
  • [26] TREM1+ tumor-associated macrophages secrete CCL7 to promote hepatocellular carcinoma metastasis
    Huang, Simin
    He, Longguang
    Zhao, Yufei
    Wei, Yuxuan
    Wang, Qiwen
    Gao, Yi
    Jiang, Xiaofeng
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (06)
  • [27] Tumor-associated macrophages derived CCL18 promotes metastasis in squamous cell carcinoma of the head and neck
    She, Li
    Qin, Yuexiang
    Wang, Juncheng
    Liu, Chao
    Zhu, Gangcai
    Li, Guo
    Wei, Ming
    Chen, Changhan
    Liu, Guancheng
    Zhang, Diekuo
    Chen, Xiyu
    Wang, Yunyun
    Qiu, Yuanzheng
    Tian, Yongquan
    Zhang, Xin
    Liu, Yong
    Huang, Donghai
    CANCER CELL INTERNATIONAL, 2018, 18
  • [28] CCL15 recruits suppressive monocytes to facilitate immune escape and disease progression in hepatocellular carcinoma (vol 69, pg 143, 2019)
    Liu, Long-Zi
    Zhang, Zhao
    Zheng, Bo-Hao
    Shi, Yang
    Duan, Men
    Ma, Li-Jie
    Wang, Zhi-Chao
    Dong, Liang-Qing
    Dong, Ping-Ping
    Shi, Jie-Yi
    Zhang, Shu
    Ding, Zhen-Bin
    Ke, Ai-Wu
    Cao, Ya
    Zhang, Xiao-Ming
    Xi, Ruibin
    Zhou, Jian
    Fan, Jia
    Wang, Xiao-Ying
    Gao, Qiang
    HEPATOLOGY, 2025, 81 (03) : E113 - E114
  • [29] Incidental parathyroid adenoma mimicking tumor recurrence in a patient with follicular thyroid carcinoma
    Ruf, J
    Seehofer, D
    Nadjari, B
    Amthauer, H
    Rayes, N
    CLINICAL NUCLEAR MEDICINE, 2006, 31 (02) : 74 - 76
  • [30] The prognostic significance of carcinoma-associated fibroblasts and tumor-associated macrophages in nasopharyngeal carcinoma
    Yu, Yahui
    Ke, Liangru
    Lv, Xing
    Ling, Yi Hong
    Lu, Jiabin
    Liang, Hu
    Qiu, Wenze
    Huang, Xinjun
    Liu, Guoying
    Li, Wangzhong
    Guo, Xiang
    Xia, Weixiong
    Xiang, Yanqun
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 1935 - 1946